Functions of the proteasome: From protein degradation and immune surveillance to cancer therapy

Biochemical Society Transactions

Volumn 35, Issue 1, 2007, Pages 12-17

  Goldberg, Alfred L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BORTEZOMIB; EPITOPE; GLOBULAR PROTEIN; GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NUCLEOTIDASE; PROTEASOME; PROTEASOME ACTIVATING NUCLEOTIDASE; PROTEASOME INHIBITOR; UBIQUITIN; UNCLASSIFIED DRUG;

CANCER SCREENING; CANCER THERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG MECHANISM; DRUG POTENTIATION; DRUG STRUCTURE; HUMAN; IMMUNE SYSTEM; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTINEOPLASTIC AGENTS; CATALYSIS; HUMANS; IMMUNE SYSTEM; MODELS, BIOLOGICAL; MODELS, CHEMICAL; NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN;

MAMMALIA;

EID: 33847066706     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/BST0350012     Document Type: Conference Paper

References (30)

1. Goldberg, A.L. and Dice, J.F. (1974) Annu. Rev. Biochem. 43, 835-869
2. Goldberg, A.L. and St. John, A.C. (1976) Annu. Rev. Biochem. 45, 747-803
3. Goldberg, A.L. (1972) Proc. Natl. Acad. Sci. U.S.A. 69, 422-426
4. Goldberg, A.L. (2005) Neuron 45, 339-344
5. Ciechanover, A. (2005) Nat. Rev. Mol. Cell. Biol. 6, 79-87
6. Etlinger, J. and Goldberg, A.L. (1977) Proc. Natl. Acad. Sci. U.S.A. 74, 54-58
7. Hershko, A. and Ciechanover, A. (1998) Annu. Rev. Biochem. 67, 425-479
8. Chung, C.H. and Goldberg, A.L. (1981) Proc. Natl. Acad. Sci. U.S.A. 78, 4931-4935
9. Gottesman, S. (1996) Annu. Rev. Genet. 30, 465-506
10. Tanaka, K., Waxman, L. and Goldberg, A.L. (1983) J. Cell Biol. 96, 1580-1585
11. Voges, D., Zwickl, P. and Baumeister, W. (1999) Annu. Rev. Biochem. 68, 1015-1068
12. Pickart, C.M. and Cohen, R.E. (2004) Nat. Rev. Mol. Cell Biol. 5, 177-187
13. Kisselev, A.F. and Goldberg, A.L. (2001) Chem. Biol. 8, 739-758
14. Smith, D., Benaroudj, N. and Goldberg, A.L. (2006) J. Struct. Biol. 156, 72-83
15. Zwickl, P., Ng, D., Woo, K.M., Klenk, H.-P. and Goldberg, A.L. (1999) J. Biol. Chem. 274, 26008-26014
16. Benaroudj, N. and Goldberg, A.L. (2000) Nat. Cell Biol. 2, 833-839
17. Benaroudj, N., Zwickl, P., Seemüller, E., Baumeister, W. and Goldberg, A.L. (2003) Mol. Cell 11, 69-78
18. Navon, A. and Goldberg, A.L. (2001) Mol. Cell 8, 1339-1349
19. Smith, D., Kafri, G., Cheng, Y., Ng, D., Walz, T. and Goldberg, A.L. (2005) Mol. Cell 20, 687-698
20. Groll, M., Bajorek, M., Kohler, A., Moroder, L., Rubin, D.M., Huber, R., Glickman, M.H. and Finley, D. (2000) Nat. Struct. Biol. 7, 1062-1067
21. Kohler, A., Cascio, P., Leggett, D.S., Woo, K.M., Goldberg, A.L. and Finley, D. (2001) Mol. Cell 7, 1143-1152
22. Lecker, S.H., Jagoe, R.T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S.R., Mitch, W.E. and Goldberg, A.L. (2004) FASEB J. 18, 39-51
23. Rock, K.L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D. and Goldberg, A.L. (1994) Cell 78, 761-771
24. Palombella, V.J., Rando, O.J., Goldberg, A.L. and Maniatis, T. (1994) Cell 78, 773-785
25. Kostova, Z. and Wolf, D.H. (2003) EMBO J. 22, 2309-2917
26. Goldberg, A.L. (2004) In Cancer Drug Discovery and Development: Proteasome Inhibitors in Cancer Therapy (Adams, J., ed.), pp. 17-38, Humana Press, Totowa, NJ
27. Kisselev, A.F., Callard, A. and Goldberg, A.L. (2006) J. Biol. Chem. 281, 8582-8590
28. Rock, K.L., York, I.A., Saric, T. and Goldberg, A.L. (2002) Adv. Immunol. 80, 1-70
29. Chang, S.C., Momburg, F., Bhutani, N. and Goldberg, A.L. (2005) Proc. Natl. Acad. Sci. U.S.A. 102, 17107-17112
30. Rechsteiner, M. and Hill, C.P. (2005) Trends Cell. Biol. 15, 27-33